# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-082619
Filing Date
2013-11-08
Accepted
2013-11-08 09:47:46
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | a13-19516_110q.htm | 10-Q | 918866
2 | EX-31.1 | a13-19516_1ex31d1.htm | EX-31.1 | 12621
3 | EX-31.2 | a13-19516_1ex31d2.htm | EX-31.2 | 12709
4 | EX-32.1 | a13-19516_1ex32d1.htm | EX-32.1 | 7832
| Complete submission text file | 0001104659-13-082619.txt |  | 6668867

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE DOCUMENT | cldx-20130930.xml | EX-101.INS | 787525
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cldx-20130930.xsd | EX-101.SCH | 73287
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cldx-20130930_cal.xml | EX-101.CAL | 71827
8 | XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT | cldx-20130930_lab.xml | EX-101.LAB | 1165951
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cldx-20130930_pre.xml | EX-101.PRE | 533389
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cldx-20130930_def.xml | EX-101.DEF | 314470

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 131202796
SIC: 2835 In Vitro & In Vivo Diagnostic Substances